Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKVIR: Once Daily Triple Therapy in HIV-1/Tuberculosis Co-infected Patients
NCT00115609Phase 3Completed
- Sponsor
- ANRS
- Start
- Jan 2006
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of efavirenz, tenofovir, emtricitabine in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Jan 2006; status: completed.
02
Drugs
efavirenztenofoviremtricitabine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00115609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115609.